Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Nephrology
•
Glomerulonephritis
Would you consider initiating eculizumab without plasmapheresis as initial therapy for a patient with renal TMA who has a low suspicion of TTP based on a scoring algorithm?
Frimat M, et al., PMID 39342982
Related Questions
How would you treat idiopathic isolated renal TMA diagnosed on renal biopsy without evidence of MAHA?
How do various therapeutic approaches for IgA nephropathy target the different stages of the four-hit hypothesis?
What would be your approach to managing severe ANCA-associated vasculitis in a patient who is also septic from a bacterial infection?
How would you approach managing an asymptomatic patient with normal kidney function who has elevated p-ANCA and MPO titers along with evidence for pauci-immune glomerulonephritis on kidney biopsy?
Under what circumstances would you consider obinutuzumab instead of rituximab when treating primary membranous nephropathy?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?
Do you use delayed-release budesonide over prednisone or methylprednisolone for the treatment of IgA nephropathy, considering the available safety and efficacy data?
Do you modify the albumin level below which you would prophylactically anticoagulate a pregnant patient with nephrotic-range proteinuria, given that hypoalbuminemia is expected in pregnancy?
What is your preferred iron loading strategy for patients with anemia of chronic kidney disease?
How do you approach distinguishing between primary and secondary FSGS in a patient who is PLA2R negative?
